Daniel Sulmasy to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Daniel Sulmasy has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.641
-
Unrealistic optimism in early-phase oncology trials. IRB. 2011 Jan-Feb; 33(1):1-8.
Score: 0.332
-
Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question? J Clin Oncol. 2012 Dec 10; 30(35):4396-400.
Score: 0.094
-
Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials. Cancer. 2005 Jan 01; 103(1):140-7.
Score: 0.055
-
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol. 2003 Jul 01; 21(13):2589-96.
Score: 0.049
-
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer. 2003 Jul 01; 98(1):166-75.
Score: 0.049
-
Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth. 2003; 24(4):329-44.
Score: 0.048
-
An exploration of relative health stock in advanced cancer patients. Med Decis Making. 2004 Nov-Dec; 24(6):614-24.
Score: 0.014